Zydus Lifesciences informs about press release

22 Jul 2024 Evaluate

Zydus Lifesciences has informed that it enclosed a copy of press release dated July 22, 2024 titled ‘Zydus receives approval from COFEPRIS of Mexico to market Bhava™ (Bevacizumab biosimilar) to treat various cancers’.

The above information is a part of company’s filings submitted to BSE.


Zydus Lifesciences Share Price

881.95 -2.90 (-0.33%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×